Vivek Rao

Title: Vivek Rao: Innovator in Tyrosine Phosphatase Research

Introduction

Vivek Rao is a distinguished inventor based in New Delhi, India. He has made significant contributions to the field of biotechnology, particularly in the study of tyrosine phosphatases. His innovative work has the potential to impact the development of anti-tubercular drugs.

Latest Patents

Vivek Rao holds a patent for a method involving mutant strains harboring a modified tyrosine phosphatase gene (mptpA or mptpB). This invention provides a method for developing mutant strains that are incapable of expressing the active tyrosine phosphatase. The mptpA or mptpB gene can be modified by replacing internal sequences with an antibiotic resistance marker gene, disrupting the expression of the active gene. Additionally, the invention includes a recombinant vector comprising the modified mptpA or mptpB, which can be used to develop mutant strains of mycobacteria. This research aims to assess the role of tyrosine phosphatases MptpA and MptpB in virulence and pathogenesis, identifying potential targets for anti-tubercular drug development. He has 1 patent to his name.

Career Highlights

Vivek Rao has worked with notable institutions such as the Indian Council of Medical Research and the University of Delhi. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant research projects.

Collaborations

Some of his notable coworkers include Anil Kumar Tyagi and Ramandeep Singh. Their collaborative efforts have further advanced the research in tyrosine phosphatases and their implications in disease.

Conclusion

Vivek Rao's innovative work in the field of biotechnology, particularly regarding tyrosine phosphatases, showcases his commitment to advancing medical research. His contributions have the potential to lead to significant breakthroughs in the fight against tuberculosis.